Di Filippo, L. D. [., Lobato Duarte, J. [., Hofstätter Azambuja, J., Isler Mancuso, R., Tavares Luiz, M., Hugo Sousa Araújo, V. [., . . . Chorilli, M. [. (2022). Glioblastoma multiforme targeted delivery of docetaxel using bevacizumab-modified nanostructured lipid carriers impair in vitro cell growth and in vivo tumor progression.
Chicago Style CitationDi Filippo, Leonardo Delello [UNESP], et al. Glioblastoma Multiforme Targeted Delivery of Docetaxel Using Bevacizumab-modified Nanostructured Lipid Carriers Impair in Vitro Cell Growth and in Vivo Tumor Progression. 2022.
MLA CitationDi Filippo, Leonardo Delello [UNESP], et al. Glioblastoma Multiforme Targeted Delivery of Docetaxel Using Bevacizumab-modified Nanostructured Lipid Carriers Impair in Vitro Cell Growth and in Vivo Tumor Progression. 2022.